Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome.
22q13
Epilepsy
Phelan-McDermid syndrome
SHANK3
Seizures
Journal
Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832
Informations de publication
Date de publication:
10 May 2024
10 May 2024
Historique:
received:
04
03
2024
accepted:
03
05
2024
medline:
11
5
2024
pubmed:
11
5
2024
entrez:
10
5
2024
Statut:
epublish
Résumé
Phelan-McDermid syndrome (PMS) is a genetic neurodevelopmental disorder caused by SHANK3 haploinsufficiency and is associated with an increased risk for seizures. Previous literature indicates that around one third of individuals with PMS also have epilepsy or seizures, with a wide range of types and ages of onset. Investigating the impact of seizures on intellectual and adaptive functioning for PMS is a primary concern for caregivers and is important to understanding the natural history of this syndrome. We report on results from 98 individuals enrolled in a prospective, longitudinal study. We detailed seizure frequency, type, and age of onset, and we analyzed seizure occurrence with best estimate IQ, adaptive functioning, clinical features, and genotype. We conducted multiple linear regression analyses to assess the relationship between the presence of seizures and the Vineland Adaptive Behavior Scale, Second Edition (VABS-II) Adaptive Behavior Composite score and the best estimate full-scale IQ. We also performed Chi-square tests to explore associations between seizure prevalence and genetic groupings. Finally, we performed Chi-square tests and t-tests to explore the relationship between seizures and demographic features, features that manifest in infancy, and medical features. Seizures were present in 41% of the cohort, and age of onset was widely variable. The presence of seizures was associated with significantly lower adaptive and intellectual functioning. Genotype-phenotype analyses were discrepant, with no differences in seizure prevalence across genetic classes, but with more genes included in deletions of participants with 22q13 deletions and seizures compared to those with 22q13 deletions and no seizures. No clinical associations were found between the presence of seizures and sex, history of pre- or neonatal complications, early infancy, or medical features. In this cohort, generalized seizures were associated with developmental regression, which is a top concern for PMS caregivers. These results begin to eludicate correlates of seizures in individuals with PMS and highlight the importance of early seizure management. Importantly, presence of seizures was associated with adaptive and cognitive functioning. A larger cohort might be able to identify additional associations with medical features. Genetic findings suggest an increased capability to realize genotype-phenotype relationships when deletion size is taken into account.
Sections du résumé
BACKGROUND
BACKGROUND
Phelan-McDermid syndrome (PMS) is a genetic neurodevelopmental disorder caused by SHANK3 haploinsufficiency and is associated with an increased risk for seizures. Previous literature indicates that around one third of individuals with PMS also have epilepsy or seizures, with a wide range of types and ages of onset. Investigating the impact of seizures on intellectual and adaptive functioning for PMS is a primary concern for caregivers and is important to understanding the natural history of this syndrome.
METHODS
METHODS
We report on results from 98 individuals enrolled in a prospective, longitudinal study. We detailed seizure frequency, type, and age of onset, and we analyzed seizure occurrence with best estimate IQ, adaptive functioning, clinical features, and genotype. We conducted multiple linear regression analyses to assess the relationship between the presence of seizures and the Vineland Adaptive Behavior Scale, Second Edition (VABS-II) Adaptive Behavior Composite score and the best estimate full-scale IQ. We also performed Chi-square tests to explore associations between seizure prevalence and genetic groupings. Finally, we performed Chi-square tests and t-tests to explore the relationship between seizures and demographic features, features that manifest in infancy, and medical features.
RESULTS
RESULTS
Seizures were present in 41% of the cohort, and age of onset was widely variable. The presence of seizures was associated with significantly lower adaptive and intellectual functioning. Genotype-phenotype analyses were discrepant, with no differences in seizure prevalence across genetic classes, but with more genes included in deletions of participants with 22q13 deletions and seizures compared to those with 22q13 deletions and no seizures. No clinical associations were found between the presence of seizures and sex, history of pre- or neonatal complications, early infancy, or medical features. In this cohort, generalized seizures were associated with developmental regression, which is a top concern for PMS caregivers.
CONCLUSIONS
CONCLUSIONS
These results begin to eludicate correlates of seizures in individuals with PMS and highlight the importance of early seizure management. Importantly, presence of seizures was associated with adaptive and cognitive functioning. A larger cohort might be able to identify additional associations with medical features. Genetic findings suggest an increased capability to realize genotype-phenotype relationships when deletion size is taken into account.
Identifiants
pubmed: 38730350
doi: 10.1186/s11689-024-09541-0
pii: 10.1186/s11689-024-09541-0
doi:
Substances chimiques
Nerve Tissue Proteins
0
SHANK3 protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
25Subventions
Organisme : NIH HHS
ID : K23NS119666
Pays : United States
Informations de copyright
© 2024. The Author(s).
Références
Sarasua SM, Boccuto L, Sharp JL, Dwivedi A, Chen CF, Rollins JD, et al. Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome. Hum Genet. 2014;133(7):847–59.
doi: 10.1007/s00439-014-1423-7
pubmed: 24481935
Nevado J, García-Miñaúr S, Palomares-Bralo M, Vallespín E, Guillén-Navarro E, Rosell J, et al. Variability in Phelan-McDermid syndrome in a cohort of 210 individuals. Front Genet. 2022;13:652454.
doi: 10.3389/fgene.2022.652454
pubmed: 35495150
pmcid: 9044489
Oberman LM, Boccuto L, Cascio L, Sarasua S, Kaufmann WE. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations. Orphanet J Rare Dis. 2015;10:105.
doi: 10.1186/s13023-015-0323-9
pubmed: 26306707
pmcid: 4549933
Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, Schwartz L, et al. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Mol Autism. 2013;4(1):18.
doi: 10.1186/2040-2392-4-18
pubmed: 23758760
pmcid: 3707861
García-Bravo C, Martínez-Piédrola RM, García-Bravo S, Rodríguez-Pérez MP, Martín-Gómez AS, Fernández-Gómez G, Palacios-Ceña D. Living with and managing seizures among parents of children diagnosed with Phelan-McDermid syndrome: a qualitative study using in-depth interviews. Eur J Pediatr. 2023. https://doi.org/10.1007/s00431-023-05285-6 .
de Coo IFM, Jesse S, Le TL, Sala C. Consensus recommendations on Epilepsy in Phelan-McDermid syndrome. Eur J Med Genet. 2023;66(6):104746.
doi: 10.1016/j.ejmg.2023.104746
pubmed: 36967043
Srivastava S, Sahin M, Buxbaum JD, Berry-Kravis E, Soorya LV, Thurm A, et al. Updated consensus guidelines on the management of Phelan-McDermid syndrome. Am J Med Genet A. 2023;191(8):2015–44.
doi: 10.1002/ajmg.a.63312
pubmed: 37392087
Holder JL Jr, Quach MM. The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutations. Epilepsia. 2016;57(10):1651–9.
doi: 10.1111/epi.13506
pubmed: 27554343
pmcid: 5547884
Figura MG, Coppola A, Bottitta M, Calabrese G, Grillo L, Luciano D, et al. Seizures and EEG pattern in the 22q13.3 deletion syndrome: clinical report of six Italian cases. Seizure. 2014;23(9):774–9.
doi: 10.1016/j.seizure.2014.06.008
pubmed: 25027555
Jain L, Oberman LM, Beamer L, Cascio L, May M, Srikanth S, et al. Genetic and metabolic profiling of individuals with Phelan-McDermid syndrome presenting with seizures. Clin Genet. 2022;101(1):87–100.
doi: 10.1111/cge.14074
pubmed: 34664257
Levy T, Foss-Feig JH, Betancur C, Siper PM, Trelles-Thorne MDP, Halpern D, et al. Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium. Hum Mol Genet. 2022;31(4):625–37.
doi: 10.1093/hmg/ddab280
pubmed: 34559195
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.
doi: 10.1038/gim.2015.30
pubmed: 25741868
pmcid: 4544753
Lord C, Rutter M, DiLavore P, Risi S, Gotham K, Bishop S, Gutrie W. (ADOS-2) Manual (Part I): modules 1–4. Autism diagnostic observation schedule. 2012.
Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659–85.
doi: 10.1007/BF02172145
pubmed: 7814313
American Psychiatric Association. Diagnostic and statistical manual of mental disorders : DSM-5. American Psychiatric A, American Psychiatric Association DSMTF, editors. Arlington: American Psychiatric Association; 2013.
Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–30.
doi: 10.1111/epi.13670
pubmed: 28276060
Mullen EM. Mullen scales of early learning manual: American Guidance Service. 1995.
Roid GH, Pomplun M. The stanford-binet intelligence scales: The Guilford Press. 2012.
Elliot C. Differential abilities scale—2nd edition (DAS-II) manual. Harcourt Assessment. 2007.
Beghi E. The Epidemiology of Epilepsy. Neuroepidemiology. 2019;54(2):185–91.
doi: 10.1159/000503831
pubmed: 31852003
Samanta D. Epilepsy in Angelman syndrome: a scoping review. Brain Dev. 2021;43(1):32–44.
doi: 10.1016/j.braindev.2020.08.014
pubmed: 32893075
Mohamed IN, Osman AH, Mohamed S, Hamid EK, Hamed AA, Alsir A, et al. Intelligence quotient (IQ) among children with epilepsy: National epidemiological study – Sudan. Epilepsy Behav. 2020;103:106813.
doi: 10.1016/j.yebeh.2019.106813
pubmed: 31937511
Gauffin H, Landtblom AM, Vigren P, Frick A, Engström M, McAllister A, Karlsson T. Similar profile and magnitude of cognitive impairments in focal and generalized epilepsy: a pilot study. Front Neurol. 2021;12:746381.
doi: 10.3389/fneur.2021.746381
pubmed: 35095714
Sillanpää M, Schmidt D. Long-term outcome of medically treated epilepsy. Seizure. 2017;44:211–6.
doi: 10.1016/j.seizure.2016.09.002
pubmed: 27646715
Thurman DJ, Logroscino G, Beghi E, Hauser WA, Hesdorffer DC, Newton CR, et al. The burden of premature mortality of epilepsy in high-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia. 2017;58(1):17–26.
doi: 10.1111/epi.13604
pubmed: 27888514